Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

15 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Primary pulmonary choriocarcinoma.
Snoj Z, Kocijancic I, Skof E. Snoj Z, et al. Among authors: Skof E. Radiol Oncol. 2016 Jun 24;51(1):1-7. doi: 10.1515/raon-2016-0038. eCollection 2017 Mar 1. Radiol Oncol. 2016. PMID: 28265226 Free PMC article.
Primary debulking surgery versus primary neoadjuvant chemotherapy for high grade advanced stage ovarian cancer: comparison of survivals.
Kobal B, Noventa M, Cvjeticanin B, Barbic M, Meglic L, Herzog M, Bordi G, Vitagliano A, Saccardi C, Skof E. Kobal B, et al. Among authors: Skof E. Radiol Oncol. 2018 Sep 11;52(3):307-319. doi: 10.2478/raon-2018-0030. Radiol Oncol. 2018. PMID: 30210049 Free PMC article. Clinical Trial.
Potential of osteopontin in the management of epithelial ovarian cancer.
Cerne K, Hadzialjevic B, Skof E, Verdenik I, Kobal B. Cerne K, et al. Among authors: Skof E. Radiol Oncol. 2019 Jan 31;53(1):105-115. doi: 10.2478/raon-2019-0003. Radiol Oncol. 2019. PMID: 30712025 Free PMC article.
Randomized prospective phase II study to compare the combination chemotherapy regimen epirubicin, cisplatin, and 5-fluorouracil with epirubicin, cisplatin, and capecitabine in patients with advanced or metastatic gastric cancer.
Ocvirk J, Reberšek M, Skof E, Hlebanja Z, Boc M. Ocvirk J, et al. Among authors: Skof E. Am J Clin Oncol. 2012 Jun;35(3):237-41. doi: 10.1097/COC.0b013e31820dc0b0. Am J Clin Oncol. 2012. PMID: 21399488 Clinical Trial.
Capecitabine plus Irinotecan (XELIRI regimen) compared to 5-FU/LV plus Irinotecan (FOLFIRI regimen) as neoadjuvant treatment for patients with unresectable liver-only metastases of metastatic colorectal cancer: a randomised prospective phase II trial.
Skof E, Rebersek M, Hlebanja Z, Ocvirk J. Skof E, et al. BMC Cancer. 2009 Apr 22;9:120. doi: 10.1186/1471-2407-9-120. BMC Cancer. 2009. PMID: 19386096 Free PMC article. Clinical Trial.
Cytology material is equivalent to tumor tissue in determining mutations of BRCA 1/2 genes in patients with tubo-ovarian high grade serous carcinoma.
Gornjec A, Novakovic S, Stegel V, Hocevar M, Pohar Marinsek Z, Gazic B, Krajc M, Skof E. Gornjec A, et al. Among authors: Skof E. BMC Cancer. 2019 Apr 2;19(1):296. doi: 10.1186/s12885-019-5535-2. BMC Cancer. 2019. PMID: 30940100 Free PMC article. Clinical Trial.
15 results
Jump to page
Feedback